Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-16-001025
Filing Date
2016-09-02
Accepted
2016-09-02 16:30:18
Documents
1
Period of Report
2016-09-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 3379
  Complete submission text file 0001593968-16-001025.txt   4871
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA NY 01862
Business Address
Dawes William C. Jr. (Reporting) CIK: 0001610673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36569 | Film No.: 161869007